BLC
CME icon

Brown, Lisle/Cummings’s CME Group CME Stock Holding History

Brown, Lisle/Cummings’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Hold
355
– – 0.03% 281
2025
Q4 		$96.9K Hold
355
– – 0.02% 286
2025
Q3 		$95.9K Hold
355
– – 0.02% 283
2025
Q2 		$97.8K Buy
355
+1
+0.3% +$272 0.03% 271
2025
Q1 		$93.9K Buy
354
+2
+0.6% +$493 0.03% 277
2024
Q4 		$81.7K Buy
352
+252
+252% +$57.9K 0.02% 285
2024
Q3 		$22.1K Hold
100
– – 0.01% 387
2024
Q2 		$19.7K Hold
100
– – 0.01% 385
2024
Q1 		$21.5K Hold
100
– – 0.01% 368
2023
Q4 		$21.1K Hold
100
– – 0.01% 361
2023
Q3 		$20K Hold
100
– – 0.01% 336
2023
Q2 		$18.5K Hold
100
– – 0.01% 348
2023
Q1 		$19.2K Hold
100
– – 0.01% 338
2022
Q4 		$16.8K Hold
100
– – 0.01% 332
2022
Q3 		$17.7K Hold
100
– – 0.01% 325
2022
Q2 		$20.5K Buy
+100
New +$21.2K 0.01% 326

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Brown, Lisle/Cummings's CME Position: Q1 2026 in Review

Brown, Lisle/Cummings held its CME Group (CME) position steady in Q1 2026 at 355 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #281.

Brown, Lisle/Cummings first reported a position in CME in Q2 2022 and has held it in 16 quarters since. 1,799 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Brown, Lisle/Cummings held 355 shares of CME Group worth $105K as of Q1 2026.
  • Brown, Lisle/Cummings left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 0.03% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #281 holding.
  • Brown, Lisle/Cummings first reported a position in CME Group in Q2 2022 and has held it in 16 quarters since.
  • 1,799 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.